Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Managing comorbid schizophrenia and substance abuse.

Drake RE, Mueser KT.

Curr Psychiatry Rep. 2001 Oct;3(5):418-22. Review.

PMID:
11559480
2.

A review of treatments for people with severe mental illnesses and co-occurring substance use disorders.

Drake RE, Mueser KT, Brunette MF, McHugo GJ.

Psychiatr Rehabil J. 2004 Spring;27(4):360-74. Review.

PMID:
15222148
3.

Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.

Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, Montoya I, Parks J, Weiss RD.

J Psychiatr Pract. 2005 Sep;11(5):315-39. Review.

4.

Treatment of co-occurring psychotic and substance use disorders.

Mueser KT, Gingerich S.

Soc Work Public Health. 2013;28(3-4):424-39. doi: 10.1080/19371918.2013.774676. Review.

PMID:
23731429
5.

Implementing dual diagnosis services for clients with severe mental illness.

Drake RE, Essock SM, Shaner A, Carey KB, Minkoff K, Kola L, Lynde D, Osher FC, Clark RE, Rickards L.

Psychiatr Serv. 2001 Apr;52(4):469-76. Review.

PMID:
11274491
6.

Enhancing validity in co-occurring disorders treatment research.

McHugo GJ, Drake RE, Brunette MF, Xie H, Essock SM, Green AI.

Schizophr Bull. 2006 Oct;32(4):655-65. Epub 2006 Jul 18. Review.

7.

Treatment of substance abusing patients with comorbid psychiatric disorders.

Kelly TM, Daley DC, Douaihy AB.

Addict Behav. 2012 Jan;37(1):11-24. doi: 10.1016/j.addbeh.2011.09.010. Epub 2011 Sep 14. Review.

8.

Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.

Horsfall J, Cleary M, Hunt GE, Walter G.

Harv Rev Psychiatry. 2009;17(1):24-34. doi: 10.1080/10673220902724599. Review.

PMID:
19205964
9.

Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.

Green AI.

J Clin Psychiatry. 2006;67 Suppl 7:31-5; quiz 36-7. Review.

10.
11.

Schizophrenia and comorbid substance use disorder: effects of antipsychotics.

Green AI.

J Clin Psychiatry. 2005;66 Suppl 6:21-6. Review.

12.

Psychosocial approaches to dual diagnosis.

Drake RE, Mueser KT.

Schizophr Bull. 2000;26(1):105-18. Review.

PMID:
10755672
13.

[Dual diagnosis of psychosis and addiction. From principles to practice].

Gouzoulis-Mayfrank E.

Nervenarzt. 2004 Jul;75(7):642-50. Review. German.

PMID:
15293008
14.

Comorbid schizophrenia and substance abuse: a review of epidemiology and course.

Westermeyer J.

Am J Addict. 2006 Sep-Oct;15(5):345-55. Review.

PMID:
16966190
15.

A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.

Brunette MF, Mueser KT, Drake RE.

Drug Alcohol Rev. 2004 Dec;23(4):471-81. Review.

PMID:
15763752
16.

Dual diagnosis and psychosocial interventions--introduction and commentary.

Thylstrup B, Johansen KS.

Nord J Psychiatry. 2009;63(3):202-8. doi: 10.1080/08039480802571069. Review.

PMID:
19034725
17.

Treating substance abuse among patients with schizophrenia.

Bellack AS, DiClemente CC.

Psychiatr Serv. 1999 Jan;50(1):75-80. Review.

PMID:
9890583
18.

Drug abuse and addiction treatment research. The next generation.

Leshner AI.

Arch Gen Psychiatry. 1997 Aug;54(8):691-4. Review. No abstract available.

PMID:
9283502
19.

Comorbid addiction and major mental illness in Europe: a narrative review.

CarrĂ  G, Bartoli F, Brambilla G, Crocamo C, Clerici M.

Subst Abus. 2015;36(1):75-81. doi: 10.1080/08897077.2014.960551. Epub 2014 Sep 15. Review.

PMID:
25222286
20.

Behavioral interventions for dual-diagnosis patients.

Goldsmith RJ, Garlapati V.

Psychiatr Clin North Am. 2004 Dec;27(4):709-25. Review.

PMID:
15550289

Supplemental Content

Support Center